<DOC>
	<DOC>NCT01225159</DOC>
	<brief_summary>To determine whether intraoperative tight glycaemic control can reduce postoperative infection, morbidity and mortality</brief_summary>
	<brief_title>Tight Glycaemic Control During Cardiac Surgery</brief_title>
	<detailed_description>Hyperglycaemia develops frequently in patients undergoing cardiac surgery, especially following cardiopulmonary bypass (CPB). Recent evidence suggests that acute hyperglycaemia adversely affects immune function, wound healing and cardiovascular function.</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>age &gt; 15 years cardiac surgery with cardiopulmonary bypass active infection insulin allergy offpump cardiopulmonary bypass procedures</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>tight glycemic control</keyword>
	<keyword>cardiac surgery</keyword>
</DOC>